HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Purpura fulminans as a sequel to erythema nodosum in a child with homozygous Leiden mutation and acquired protein S deficiency.

AbstractUNLABELLED:
A 6-y-old boy presented with generalized, bruise-like swelling of both legs. Three weeks later, he developed purpura fulminans in one of the affected feet. Histology of the leg swelling was in accordance with erythema nodosum. The boy proved to be homozygous for the Factor V Leiden mutation and to have acquired protein S deficiency. He recovered, with partial loss of two toes.
CONCLUSION:
In contrast to what is often stated, erythema nodosum is not always a benign condition. On the basis of this report, we suggest that if extensive erythema nodosum develops in an individual without any known thrombophilic disorder, investigations with respect to the latter should be performed.
AuthorsCathrine Foyn Bruun, Bodil Langbakk, Sonja Eriksson Steigen
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 94 Issue 8 Pg. 1155-8 (Aug 2005) ISSN: 0803-5253 [Print] Norway
PMID16188867 (Publication Type: Case Reports, Journal Article)
Chemical References
  • factor V Leiden
  • Warfarin
  • Factor V
  • Heparin
  • Prednisolone
Topics
  • Biopsy, Needle
  • Child
  • Combined Modality Therapy
  • Erythema Nodosum (complications, diagnosis, therapy)
  • Factor V (genetics)
  • Follow-Up Studies
  • Heparin (therapeutic use)
  • Humans
  • IgA Vasculitis (complications, diagnosis, therapy)
  • Immunohistochemistry
  • Male
  • Plasma Exchange
  • Point Mutation
  • Prednisolone (therapeutic use)
  • Protein S Deficiency (complications, diagnosis, genetics, therapy)
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: